World's Best Scientists 2026 revealed!
Marvin J. Fritzler

Marvin J. Fritzler

D-Index & Metrics

Immunology

D-Index
77
Citations
19194
World Ranking
1841
National Ranking
38

Medicine

D-Index
78
Citations
19397
World Ranking
18149
National Ranking
764

Marvin J. Fritzler publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marvin J. Fritzler sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 399 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marvin J. Fritzler D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marvin J. Fritzler sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 77 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marvin J. Fritzler is affiliated with the University of Calgary in Canada and has contributed extensively to the fields of medicine, with a focus on rheumatology and immunology. Their research spans various subfields, including epidemiology, pathology and forensic medicine, and radiology, nuclear medicine, and imaging.

The scientist has a significant body of work concentrated on several main topics:

  • Systemic Lupus Erythematosus Research
  • Systemic Sclerosis and Related Diseases
  • Inflammatory Myopathies and Dermatomyositis
  • Monoclonal and Polyclonal Antibodies Research
  • Immunodeficiency and Autoimmune Disorders
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • COVID-19 Clinical Research Studies

Marvin J. Fritzler has published numerous papers. Recent examples include:

  • Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19, 2021, Nature Medicine
  • 2020 international consensus on ANCA testing beyond systemic vasculitis, 2020, Autoimmunity Reviews
  • A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus, 2020, Autoimmunity Reviews
  • Circulating Calprotectin as a Biomarker of COVID-19 Severity, 2021, Expert Review of Clinical Immunology
  • Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies, 2021, Autoimmunity Reviews

Their frequent co-authors include:

  • May Y. Choi
  • Marie Hudson
  • Minoru Satoh
  • Sasha Bernatsky
  • Michael Mähler

Marvin J. Fritzler's work has been published predominantly in several key venues:

  • Annals of the Rheumatic Diseases
  • Autoimmunity Reviews
  • Frontiers in Immunology
  • Lara D. Veeken
  • The Journal of Rheumatology

The research demonstrates a broad expertise across the investigation of autoimmune disorders and clinical immunology, with an emphasis on conditions such as systemic lupus erythematosus and systemic sclerosis. Their involvement in studies related to COVID-19 reflects engagement with emerging clinical challenges.

Best Publications

  • Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis

    Martial Koenig;Marvin J. Fritzler;André Roussin

  • Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective

    Jan Damoiseaux;Luis Eduardo Coelho Andrade;Orlando Gabriel Carballo;Karsten Conrad

  • Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.

    Michael Mahler;Frederick W. Miller;Marvin J. Fritzler

  • Autoantibodies in systemic sclerosis.

    Sonal Mehra;Jennifer Walker;Karen Patterson;Marvin J. Fritzler

  • Latest update on the Ro/SS-A autoantibody system.

    J. Schulte-Pelkum;M. Fritzler;M. Mahler

  • Pulmonary involvement in systemic sclerosis: Associations with genetic, serologic, sociodemographic, and behavioral factors

    Terry A. McNearney;Terry A. McNearney;John D. Reveille;Michael Fischbach;Alan W. Friedman

  • Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls

    Frank C. Arnett;Pravitt Gourh;Sanjay Shete;Chul W Ahn

  • Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.

    Martial Koenig;Marvin J. Fritzler;Ira N. Targoff;Yves Troyanov

  • Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.

    Sarthak Sinha;Nicole L Rosin;Rohit Arora;Elodie Labit

  • Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.

    Andreea Ioan-Facsinay;Annemiek Willemze;David B. Robinson;Christine A. Peschken

  • Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases.

    Judy A Savige;Wayne Dimech;Marvin Fritzler;James Goeken

  • Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors.

    M J Fritzler;J D Pauls;T D Kinsella;T J Bowen

  • Molecular cloning of a novel 97-kd Golgi complex autoantigen associated with Sjögren's syndrome.

    Kevin J. Griffith;Edward K. L. Chan;Chien‐Cheng Lung;John C. Hamel

  • Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

    Michael Mahler;Pier Luigi Meroni;Xavier Bossuyt;Marvin J. Fritzler

  • Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis

    Arnett Fc;Reveille Jd;Goldstein R;Pollard Km

  • Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology.

    Harry E. Peery;Gregory S. Day;Shannon Dunn;Marvin J. Fritzler

  • A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis

    O Nadashkevich;P Davis;M Fritzler;W Kovalenko

  • A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity.

    Eng M. Tan;Josef S. Smolen;J. S. McDougal;Brian T. Butcher

  • Addendum to the International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies

    Judy Savige;Wayne Dimech;Marvin Fritzler;James Goeken

  • Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort

    Shervin Assassi;Roozbeh Sharif;Robert E. Lasky;Terry A. McNearney

Frequent Co-Authors

Michael Mahler
Michael Mahler Heidelberg University
Edward K. L. Chan
Edward K. L. Chan University of Florida
Minoru Satoh
Minoru Satoh RMIT University
Janet E. Pope
Janet E. Pope University of Western Ontario
Jerome B. Rattner
Jerome B. Rattner University of Calgary
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Jan Damoiseaux
Jan Damoiseaux Maastricht University
Ann E. Clarke
Ann E. Clarke University of Calgary
Paul R. Fortin
Paul R. Fortin Université Laval

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, expanding into specialized nursing roles can open diverse career opportunities. Programs like the best pmhnp programs offer strong clinical placement rates, ensuring practical experience that complements immunology research and practice.

Cost is an important consideration when choosing further education. Many aspiring nurses seek out the cheapest pmhnp certificate programs to balance quality education with affordability, making it easier to advance their careers without excessive debt.

Understanding potential earnings can guide career decisions. For instance, the how much do dnps make resource provides critical salary insights for Doctor of Nursing Practice holders across the U.S., aiding financial planning for advanced degree holders.

Additionally, transitioning between nurse practitioner specializations is feasible with proper certification. Those considering a shift can explore pathways such as the acute care np certification, which opens doors to acute care settings closely linked to immunological patient care.

Best Scientists Citing Marvin J. Fritzler

Trending Scientists

Recently Published Articles